171 related articles for article (PubMed ID: 10832225)
1. Granulocyte macrophage-colony stimulating factor (GM-CSF) in neonatal neutropenia.
Ray M; Mukhopadhyay K; Narang A
Indian J Pediatr; 2000 Jan; 67(1):67-8. PubMed ID: 10832225
[TBL] [Abstract][Full Text] [Related]
2. A randomized trial of granulocyte-macrophage colony-stimulating factor in neonates with sepsis and neutropenia.
Bilgin K; Yaramiş A; Haspolat K; Taş MA; Günbey S; Derman O
Pediatrics; 2001 Jan; 107(1):36-41. PubMed ID: 11134431
[TBL] [Abstract][Full Text] [Related]
3. Myeloid colony-stimulating factors: use in the newborn.
Sreenan C; Osiovich H
Arch Pediatr Adolesc Med; 1999 Sep; 153(9):984-8. PubMed ID: 10482217
[TBL] [Abstract][Full Text] [Related]
4. Comparison of recombinant granulocyte colony-stimulating factor, recombinant human granulocyte-macrophage colony-stimulating factor and placebo for treatment of septic preterm infants.
Ahmad A; Laborada G; Bussel J; Nesin M
Pediatr Infect Dis J; 2002 Nov; 21(11):1061-5. PubMed ID: 12442030
[TBL] [Abstract][Full Text] [Related]
5. Neonatal neutropenia: what diagnostic evaluation is needed and when is treatment recommended?
Del Vecchio A; Christensen RD
Early Hum Dev; 2012 May; 88 Suppl 2():S19-24. PubMed ID: 22633505
[TBL] [Abstract][Full Text] [Related]
6. [Hematopoietic growth factors in prevention and therapy of infectious complications in premature and newborn infants].
Lehrnbecher T
Z Geburtshilfe Neonatol; 2001; 205(5):167-73. PubMed ID: 11727663
[TBL] [Abstract][Full Text] [Related]
7. Role of G-CSF GM-CSF in the management of infections in preterm newborns: an update.
Castagnola E; Dufour C
Early Hum Dev; 2014 Sep; 90 Suppl 2():S15-7. PubMed ID: 25220119
[TBL] [Abstract][Full Text] [Related]
8. A randomized, controlled trial of prophylactic granulocyte-macrophage colony-stimulating factor in human newborns less than 32 weeks gestation.
Carr R; Modi N; Doré CJ; El-Rifai R; Lindo D
Pediatrics; 1999 Apr; 103(4 Pt 1):796-802. PubMed ID: 10103305
[TBL] [Abstract][Full Text] [Related]
9. Effects of a formulary change from granulocyte colony-stimulating factor to granulocyte-macrophage colony-stimulating factor on outcomes in patients treated with myelosuppressive chemotherapy.
Wong SF; Chan HO
Pharmacotherapy; 2005 Mar; 25(3):372-8. PubMed ID: 15843284
[TBL] [Abstract][Full Text] [Related]
10. Potential use of granulocyte colon-stimulating factor and granulocyte-macrophage colony-stimulating factor in neonates.
Bracho F; Goldman S; Cairo MS
Curr Opin Hematol; 1998 May; 5(3):215-20. PubMed ID: 9664163
[TBL] [Abstract][Full Text] [Related]
11. Neutropenia in the newborn.
Maheshwari A
Curr Opin Hematol; 2014 Jan; 21(1):43-9. PubMed ID: 24322487
[TBL] [Abstract][Full Text] [Related]
12. Granulocyte-macrophage colony-stimulating factor in the treatment of neonates with neutropenia and sepsis.
Venkateswaran L; Wilimas JA; Dancy R; Wang WC; Korones S; Hayden J; Hayes FA
Pediatr Hematol Oncol; 2000 Sep; 17(6):469-73. PubMed ID: 10989467
[TBL] [Abstract][Full Text] [Related]
13. Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor have differential effects on neonatal and adult neutrophil survival and function.
Molloy EJ; O'Neill AJ; Grantham JJ; Sheridan-Pereira M; Fitzpatrick JM; Webb DW; Watson RW
Pediatr Res; 2005 Jun; 57(6):806-12. PubMed ID: 15718363
[TBL] [Abstract][Full Text] [Related]
14. Granulocyte-macrophage colony stimulating factor administered as prophylaxis for reduction of sepsis in extremely preterm, small for gestational age neonates (the PROGRAMS trial): a single-blind, multicentre, randomised controlled trial.
Carr R; Brocklehurst P; Doré CJ; Modi N
Lancet; 2009 Jan; 373(9659):226-33. PubMed ID: 19150703
[TBL] [Abstract][Full Text] [Related]
15. Preliminary report: rhG-CSF may reduce the incidence of neonatal sepsis in prolonged preeclampsia-associated neutropenia.
Kocherlakota P; La Gamma EF
Pediatrics; 1998 Nov; 102(5):1107-11. PubMed ID: 9794941
[TBL] [Abstract][Full Text] [Related]
16. Neutropenia in an extremely premature infant treated with recombinant human granulocyte colony-stimulating factor.
Roberts RL; Szelc CM; Scates SM; Boyd MT; Soderstrom KM; Davis MW; Glaspy JA
Am J Dis Child; 1991 Jul; 145(7):808-12. PubMed ID: 1711773
[TBL] [Abstract][Full Text] [Related]
17. Granulocyte and granulocyte-macrophage colony-stimulating factors in cord and maternal serum at delivery.
Bailie KE; Irvine AE; Bridges JM; McClure BG
Pediatr Res; 1994 Feb; 35(2):164-8. PubMed ID: 7513077
[TBL] [Abstract][Full Text] [Related]
18. A randomized, double-masked, placebo-controlled trial of recombinant granulocyte colony-stimulating factor administration to preterm infants with the clinical diagnosis of early-onset sepsis.
Miura E; Procianoy RS; Bittar C; Miura CS; Miura MS; Mello C; Christensen RD
Pediatrics; 2001 Jan; 107(1):30-5. PubMed ID: 11134430
[TBL] [Abstract][Full Text] [Related]
19. Granulocyte colony-stimulating factor in the cord blood of premature neonates born to mothers with pregnancy-induced hypertension.
Tsao PN; Teng RJ; Tang JR; Yau KI
J Pediatr; 1999 Jul; 135(1):56-9. PubMed ID: 10393604
[TBL] [Abstract][Full Text] [Related]
20. Hematopoietic growth factors in patients receiving intensive chemotherapy for malignant disorders: studies of granulocyte-colony stimulating factor (G-CSF), granulocyte-macrophage colony stimulating factor (GM-CSF), interleukin-3 (IL-3) and Flt-3 ligand (Flt3L).
Bruserud O; Foss B; Petersen H
Eur Cytokine Netw; 2001; 12(2):231-8. PubMed ID: 11399510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
